Are you interested in sharing your experiences of managing patients living with SM and/or treating patients taking AYVAKIT® (avapritinib) with peers?

SM is a rare disease that can pose unique challenges for healthcare providers (HCPs) due to the limited information available. Blueprint Medicines (“Blueprint”) is compiling an online directory tool (the “Directory”) as a source of demographic and professional information of HCPs who have volunteered to answer questions and advance awareness in the provider community. HCPs who volunteer to be listed in the Directory are not agents of Blueprint for this purpose; any discussions they may have related to this Directory are independent.

What is the SM Provider Peer Directory?

This HCP Directory tool includes the contact information of HCPs who have experience treating patients with SM and/or patients taking AYVAKIT and are willing to discuss their experience with other HCPs. HCP enrollment and participation in the Directory is voluntary and free of charge and is based solely on information provided by the listed HCP. Participation in the Directory is open to all qualifying HCPs and is not contingent upon the recommendation or use of any Blueprint Medicines product.

This Directory is not intended for use by patients or other HCPs to identify potential treating providers. No fees have been received by Blueprint Medicines or paid to HCPs in exchange for listing in this Directory or for any related discussions or services.

By volunteering for inclusion in the SM Provider Peer Directory, you can help raise awareness for this rare disease with the goal of improving care and disease management for patients living with SM.

What do you need to be eligible to be listed in the Directory?

Blueprint asks that registrants, through self-verification, attest that:

  • You are a healthcare provider in good standing
  • Within the past 2 years you have:
    • Seen or managed at least 3 patients with SM (indolent and/or advanced)
      AND/OR
    • Treated at least 2 patients living with SM (indolent and/or advanced) taking AYVAKIT
  • You are willing to speak to peer HCPs who have questions about your relevant medical experience

How will your information be displayed?

When the Directory is published, HCPs will be able to access and view registrants’ contact information. Publication of the Directory depends on several factors, including, but not limited to, HCP participation. Blueprint reserves the right to cease usage of the tool at any time. Should you wish to remove or alter your listing or have questions, please email smhcpdirectory@blueprintmedicines.com.

Interested in registering?

For potential inclusion of your contact information in this Directory, please fill out the form below. Please note, participation is voluntary and not compensated. If you register, Blueprint may reach out on a biyearly basis to confirm you wish to continue to be listed and that the information provided is still accurate.


*Indicates required field.






For address details below, please use your institution/practice information.







Please select all that apply. Control (or command) + click to select more than 1 option.

Please select all that apply. Control (or command) + click to select more than 1 option. Your selection(s) will be displayed in the Directory to inform users of the type(s) of SM in which you have experience.

Your selection will be displayed in the Directory to inform users if you have clinical experience with AYVAKIT.

Please select all that apply. Control (or command) + click to select more than 1 option. This will inform Directory users which contact method is preferred when reaching out.

Please note, NPI numbers will not be listed in the Directory.

Please check the boxes below in order to complete your submission to Blueprint's HCP Directory.*

Blueprint is developing this HCP directory tool (the “Directory”) as a source of demographic and professional information for HCPs who express a willingness to discuss their experience with treating patients with SM, a rare disease, with other HCPs. This Directory will reflect HCPs who have voluntarily opted in and self-reported that they have experience within the past 2 years seeing or managing at least 3 patients living with SM (indolent and/or Advanced) and/or treating at least 2 patients living with SM (indolent and/or Advanced) taking AYVAKIT. Blueprint does not verify HCP credentials or expertise. The information included in the Directory is subject to change and will reside on SMdirectory.com and be linked from Blueprint’s HCP product and disease education websites. No fees have been received by Blueprint or paid to HCPs in exchange for listing in this Directory, any related discussions, or any services. HCPs listed in the Directory are not agents of or in any way associated with Blueprint. Further, inclusion in this Directory does not represent an endorsement, a referral, or a recommendation from Blueprint. Participation in the Directory is open to all qualifying HCPs and is not contingent upon recommendation or use of any Blueprint product. Blueprint is not responsible for the accuracy of the content provided by any participating HCP in the Directory, nor any subsequent discussions or actions of participating HCPs involving users of the Directory. This Directory is not intended for use by patients or other HCPs to identify potential providers for treatment.

Thank you for your consideration, and we hope you choose to join this growing community of SM provider peers.